Following the committee meeting on 3rd February 2026, NICE is working with the companies and NHS England to finalise the recommendations. The committee doesn’t need any further information or analysis, and we don’t anticipate any further committee meetings will be required. We anticipate being able to update stakeholders by w/c 9 March 2026.
Final commercial discussions are still ongoing. The recommendations will be communicated in full once the commercial discussions are concluded and the guidance document is published on the website. We will give an indication of the anticipated guidance publication date when it is available.
Further to the last update of 12 March 2026, we can now confirm that we anticipate sending the final draft guidance confidentially to stakeholders in the week commencing 4 May 2026 and publishing it on the NICE website 1 week later.
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 806 KB) Published: 05 January 2024